Leveraging the genetics of psychiatric disorders to prioritize potential drug targets and compounds. Parker N, Koch E, Shadrin AA, Fuhrer J, et al. Neuropsychopharmacology 2026;51:1300-1309.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Parker N, Koch E, Shadrin AA, Fuhrer J, et al. Leveraging the genetics of psychiatric disorders to prioritize potential drug targets and compounds. Neuropsychopharmacology 2026;51:1300-1309.
PMID: 41795042